Table 3.
Clinical manifestations of patients with CMV anterior uveitis included number of antiglaucoma drugs and frequency of steroid eye drops in a day before and after topical 2% ganciclovir therapy
| Patient no. | Clinical before topical 2% ganciclovir |
Clinical after topical 2% ganciclovir 12 months |
Status of topical ganciclovir at 12 months | No. of recurrent | Trabeculectomy with mitomycin C | ||||||||||
| Visual acuity |
Cell | KPs | IOP | G | S | Visual acuity | Cell | KPs | IOP | G | S | ||||
| 1 | 20/25 | 1+ | + | 17 | 3 | 4 | 20/25 | 0 | 17 | 2 | 0 | Off | 1 | ||
| 2 | 20/32 | 0.5 | + | 30 | 4 | 4 | 20/20 | 0 | − | 16 | 1 | 1 | Once a day | 2 | |
| 3 | 20/20 | 0.5 | + | 32 | 2 | 10 | 20/20 | 0 | − | 12 | 0 | 0 | Off | 0 | |
| 4 | 20/60 | 1 | + | 28 | 4 | 2 | 20/25 | 0 | − | 11 | 1 | 0 | Once a day | 0 | |
| 5 | 20/40 | 0.5 | + | 13 | 4 | 4 | 20/25 | 0 | − | 10 | 0 | 2 | Off (at 6 months) |
1 | 9th month |
| 6 | 20/32 | 0.5 | + | 40 | 3 | 6 | 20/20 | 0 | + | 13 | 0 | 0 | Three times a day | 1 | |
| 7 | 20/25 | 0 | + | 14 | 2 | 4 | 20/20 | 0 | − | 8 | 0 | 0 | Three times a day | 1 | |
| 8 | HM | 4+ | − | 33 | 6 | 16 | 20/200 | 0.5 | − | 16 | 2 | 4 | Once a day | 0 | |
| 9 | 20/100 | 0.5 | + | 44 | 4 | 4 | 20/50 | 0 | − | 6 | 0 | 0 | Off | 0 | 2nd month |
| 10 | FC2 | 0.5 | + | 15 | 1 | 4 | HM | 0 | − | 1 | 1 | 1 | Off | 0 | |
| 11 | FC1 | 0 | + | 15 | 0 | 4 | FC1’ | 0 | − | 17 | 2 | 4 | Once a day (6 months) | 1 | |
G, the number of antiglaucoma drugs.
S, the frequency of steroid drops per day.
CMV, cytomegalovirus; FC, finger count; HM, hand motion; IOP, intraocular pressure; KP, keratic precipitate.